Inhibiting growth of mammary adenocarcinoma

Details Inhibiting growth of mammary adenocarcinoma Inhibiting growth of mammary adenocarcinoma

1994-02-14

1997-03-18

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

A61K 3119

Patent

active

056123744

ABSTRACT:
Growth of mammary adenocarcinoma in a mammal can be inhibited by orally administering a therapeutically effective dosage of pyruvate in the form of sodium pyruvate, calcium pyruvate or organic esters of pyruvate or precursors of pyruvate.

REFERENCES:
patent: 4158057 (1979-06-01), Stanko
patent: 4351835 (1982-09-01), Stanko
patent: 4415576 (1983-11-01), Stanko
patent: 4548937 (1985-10-01), Stanko
patent: 4812479 (1989-03-01), Stanko
patent: 4874790 (1989-10-01), Stanko
patent: 5134162 (1992-07-01), Stanko
patent: 5256697 (1993-10-01), Miller et al.
patent: 5283260 (1994-02-01), Miller et al.
patent: 5294641 (1994-03-01), Stanko
Stanko et al Pyruvate Inhibits Growth of Mammary Adeno-Carcinoma 13762 in Rats, Cancer Research 54, 1004-1007, 1994.
O'Donnell-Tormey et al., J. Exp. Med. (1987 Feb. 1) 165 (2) 500-14.
Olivotto et al., Toxicol. Pathol. (1984), 12(4), 369-73.

Affiliated with

Also associated with

Rating

Inhibiting growth of mammary adenocarcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibiting growth of mammary adenocarcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibiting growth of mammary adenocarcinoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1706705